Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-134-VI | THZ531 | 0.0001 | 1.2911 | -0.03991 |
| SUM1315MO2 | Alvocidib | 0.0001 | 1.2911 | -0.02045 |
| MDA-MB-157 | Ribociclib | 0.0316227766017 | 1.2924 | -0.03058 |
| HCC1428 | GSK2334470 | 0.1 | 1.2946 | -0.00695 |
| HCC1428 | AZD5363 | 0.01 | 1.2946 | -0.00787 |
| CAL-120 | AZD6738 | 0.316227766017 | 1.2947 | -0.00294 |
| CAMA-1 | MK 1775 | 0.01 | 1.2949 | -0.00437 |
| T47D | AZD6738 | 3.16227766 | 1.2968 | -0.00745 |
| SUM1315MO2 | RO-3306 | 0.031622777 | 1.2972 | -0.04760 |
| CAMA-1 | GSK2334470 | 0.316227766017 | 1.2999 | -0.00129 |
| MDA-MB-134-VI | AZD6738 | 0.1 | 1.3004 | -0.03336 |
| MDA-MB-361 | RO-3306 | 0.001 | 1.3010 | -0.00294 |
| CAMA-1 | RO-3306 | 0.001 | 1.3010 | -0.00322 |
| T47D | AZD6738 | 0.1 | 1.3012 | -0.01062 |
| MDA-MB-134-VI | RO-3306 | 0.316227766017 | 1.3050 | -0.03561 |
| CAMA-1 | THZ531 | 0.01 | 1.3070 | -0.00040 |
| MDA-MB-157 | AZD5363 | 0.00316227766017 | 1.3073 | -0.01879 |
| MDA-MB-134-VI | AZD5363 | 0.0316227766017 | 1.3097 | -0.02520 |
| HCC1500 | Alvocidib | 0.0001 | 1.3101 | -0.21107 |
| SUM1315MO2 | AZD6738 | 0.031622777 | 1.3107 | -0.00812 |
| HCC1428 | MK 1775 | 0.1 | 1.3108 | -0.00249 |
| CAMA-1 | AZD6738 | 0.01 | 1.3114 | -0.00212 |
| MDA-MB-134-VI | Ulixertinib | 0.003162278 | 1.3144 | -0.04103 |
| T47D | AZD6738 | 0.316227766 | 1.3154 | -0.00758 |
| HCC1428 | SHP099 | 10.0 | 1.3189 | 0.00379 |